Lannett Company Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.30 | $11.59 | 4.29% | 9 | $18.46B |
| AUROPHARMA | Aurobindo Pharma | Outperform |
18
|
Rp1.16k | Rp1.09k | 1.73% | 20 | Rp653.50B |
| APN | Aspen Pharmacare Holdings | Outperform |
18
|
R231.74 | R202.49 | 1.47% | 1 | R102.44B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.83 | £28.11 | 47.30% | 9 | £4.42B |
| RICHTER | Outperform |
18
|
Ft9.44k | Ft11.02k | 23.94% | 2 | Ft1.75T | |
| KRKG | Krka, d. d. | Buy |
18
|
126.00€ | 119.80€ | 13.10% | 0 | 3.88€B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$30.10 | $44.75 | 32.89% | 0 | $4.19B |
| GLENMARK | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.01k | Rp767.80 | -10.03% | 9 | Rp282.09B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.75 | $6.13 | 18.52% | 1 | $2.09B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.74 | $69.00 | 45.06% | 0 | $2.09B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$29.16 | $41.00 | 40.60% | 0 | $1.72B |
| AIP | Adcock Ingram Holdings | Hold |
16
|
R54.62 | R55.97 | 2.53% | 1 | R8.41B |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.17 | $10.86 | 268.66% | 3 | $255.37M |
| ASRT | Assertio Holdings | Buy |
8
|
$1.02 | $3.50 | 194.12% | 2 | $100.36M |